OSTEONIC CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,395 KRW | +0.57% |
|
+0.23% | -8.82% |
| 2023 | Tranche Update on OSTEONIC Co., Ltd.'s Equity Buyback Plan announced on October 24, 2022. | CI |
| 2023 | Tranche Update on OSTEONIC Co., Ltd.'s Equity Buyback Plan announced on October 24, 2022. | CI |
| Sales 2022 | 19.84B 14.4M | Sales 2023 | 27.8B 20.18M | Capitalization | 95.45B 69.29M |
|---|---|---|---|---|---|
| Net income 2022 | 836M 607K | Net income 2023 | 3.66B 2.66M | EV / Sales 2022 | 2.63 x |
| Net cash position 2022 | 3B 2.18M | Net cash position 2023 | 2.78B 2.02M | EV / Sales 2023 | 3.33 x |
| P/E ratio 2022 |
677
x | P/E ratio 2023 |
25.1
x | Employees | 130 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.8% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.57% | ||
| 1 week | +0.23% | ||
| Current month | -12.62% | ||
| 1 month | -14.49% | ||
| 3 months | -16.13% | ||
| 6 months | +7.06% | ||
| Current year | -8.82% |
1 week
4 300.00
4 550.00
1 month
4 150.005 260.00
Current year
4 150.006 050.00
1 year
3 510.007 080.00
3 years
2 290.007 080.00
5 years
1 160.007 080.00
10 years
1 160.0012 333.33
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Won Lee
CEO | Chief Executive Officer | 55 | 12-02-29 |
Eui-Sik Jeong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hyun-Jun Choi
BRD | Director/Board Member | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong-Won Lee
CEO | Chief Executive Officer | 55 | 12-02-29 |
Seok-Tae Choi
BRD | Director/Board Member | 55 | - |
Hyun-Jun Choi
BRD | Director/Board Member | 50 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 4,395 | +0.57% | 98,929 |
| 24-04-19 | 4,370 | -2.02% | 75,506 |
| 24-04-18 | 4,460 | +2.29% | 89,753 |
| 24-04-17 | 4,360 | -2.90% | 190,345 |
| 24-04-16 | 4,490 | +2.39% | 220,498 |
End-of-day quote Korea S.E., April 21, 2024
More quotes
OSTEONIC Co., Ltd. is a Korea-based company mainly engaged in the manufacture and distribution of medical equipment. The Companyâs products mainly include cranio maxilla facial (CMF) systems and trauma systems. The products, including plates and screws, are used for fixing and healing broken bones in cranium, face, jaw, hands and feet. The Company also manufactures other medical equipment which is used in the process of fixing implants. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-05-27
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.82% | 63.13M | |
| +9.42% | 125B | |
| -8.11% | 10.48B | |
| -3.67% | 8.42B | |
| +10.71% | 6.82B | |
| +24.48% | 4.96B | |
| +7.41% | 3.41B | |
| -0.91% | 3.04B | |
| -10.69% | 2.1B | |
| -11.48% | 1.97B |
- Stock Market
- Equities
- A226400 Stock
